Literature DB >> 21795826

Cutaneous Mycobacterium kansasii infection in a patient with AIDS post initiation of antiretroviral therapy.

Mohammed Mitha1, Preneshni Naicker, Jantjie Taljaard.   

Abstract

The HIV pandemic has resulted in unique clinical presentations in patients, and their diagnosis and management pose challenges to physicians in the developing world. Due to limited resources and difficulties in laboratory diagnosis, most physicians treat according to the most likely etiological agent that might be causing the disease. In South Africa, when acid-fast bacilli are detected, anti-tuberculous treatment is commenced. However, it must be realized that not all acid-fast bacilli are Mycobacterium tuberculosis, and that there are nontuberculous mycobacteria that can cause infections. Clinicians should work closely with the medical microbiologist when unique cases arise to ensure optimal microbial detection, identification, and patient management. This paper describes a very rare case of self-resolving cutaneous Mycobacterium kansasii infection following the initiation of antiretroviral therapy and potentially associated with immune reconstitution inflammatory syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795826     DOI: 10.3855/jidc.1733

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  3 in total

Review 1.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

2.  Abscess resulting from Mycobacterium kansasii in the left thigh of AIDS patient.

Authors:  Catarina Tenório de Lima; Vera Magalhães
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

3.  Understanding cutaneous tuberculosis: two clinical cases.

Authors:  Flavio De Maio; Enrico Maria Trecarichi; Elena Visconti; Maurizio Sanguinetti; Giovanni Delogu; Michela Sali
Journal:  JMM Case Rep       Date:  2016-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.